Close Menu

NEW YORK (GenomeWeb) – Biocept today announced an agreement to participate in MultiPlan's national primary preferred provider organization and complementary network.

Under the terms of the agreement, patients in MultiPlan's networks will have access to Biocept's liquid biopsy diagnostic services, effective August 1. MultiPlan is a national healthcare organization under contract with almost 900,000 providers, Biocept said in a statement, adding about 68 million consumers access the healthcare cost management firm's networks.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Rady Children's Institute for Genomic Medicine and Deloitte are looking into the use of drones to transport samples for testing. 

Direct-to-consumer genetic testing firm 23andMe is laying off about 100 people.

Researchers from Northwestern University examined dust for antibiotic-resistance genes, New Scientist reports. 

In Science this week: researchers present a computational method for predicting cellular differentiation state from single-cell RNA sequencing data, and more.